IRIS Institutional Research Information System - OPENBS Open Archive UniBS

COLLO, LUIGIA RINALDA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.499
AS - Asia 3.110
EU - Europa 2.832
SA - Sud America 603
AF - Africa 68
OC - Oceania 13
Continente sconosciuto - Info sul continente non disponibili 9
Totale 12.134
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.402
SG - Singapore 1.112
CN - Cina 1.084
PL - Polonia 676
UA - Ucraina 599
BR - Brasile 498
IT - Italia 378
DE - Germania 289
HK - Hong Kong 279
VN - Vietnam 206
FR - Francia 198
FI - Finlandia 190
GB - Regno Unito 149
TR - Turchia 103
RU - Federazione Russa 94
IE - Irlanda 93
IN - India 93
BD - Bangladesh 80
CA - Canada 54
AR - Argentina 43
CH - Svizzera 39
BE - Belgio 28
ID - Indonesia 27
MX - Messico 24
IQ - Iraq 22
NL - Olanda 21
EC - Ecuador 20
NG - Nigeria 20
AT - Austria 19
IR - Iran 16
ZA - Sudafrica 15
CZ - Repubblica Ceca 14
AU - Australia 12
ES - Italia 12
SE - Svezia 12
JP - Giappone 11
MA - Marocco 11
CL - Cile 10
CO - Colombia 9
EU - Europa 9
KZ - Kazakistan 9
SA - Arabia Saudita 9
PE - Perù 8
VE - Venezuela 8
UZ - Uzbekistan 7
AE - Emirati Arabi Uniti 6
JO - Giordania 6
PK - Pakistan 6
CR - Costa Rica 5
EG - Egitto 5
ET - Etiopia 5
PA - Panama 5
DZ - Algeria 4
KE - Kenya 4
KR - Corea 4
OM - Oman 4
LB - Libano 3
LT - Lituania 3
BH - Bahrain 2
BO - Bolivia 2
DO - Repubblica Dominicana 2
GR - Grecia 2
HR - Croazia 2
HU - Ungheria 2
IL - Israele 2
KG - Kirghizistan 2
LU - Lussemburgo 2
MD - Moldavia 2
MY - Malesia 2
NP - Nepal 2
PT - Portogallo 2
PY - Paraguay 2
SI - Slovenia 2
TM - Turkmenistan 2
TN - Tunisia 2
TT - Trinidad e Tobago 2
UY - Uruguay 2
AF - Afghanistan, Repubblica islamica di 1
AM - Armenia 1
AO - Angola 1
AZ - Azerbaigian 1
BB - Barbados 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
CG - Congo 1
CY - Cipro 1
DK - Danimarca 1
GE - Georgia 1
GT - Guatemala 1
GY - Guiana 1
HN - Honduras 1
JM - Giamaica 1
KI - Kiribati 1
LV - Lettonia 1
PH - Filippine 1
PR - Porto Rico 1
QA - Qatar 1
SK - Slovacchia (Repubblica Slovacca) 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
Totale 12.133
Salva come PNG Salva come JPEG
Città #
Warsaw 675
Singapore 630
Woodbridge 481
Ashburn 478
Fairfield 463
Jacksonville 437
Houston 286
Hong Kong 275
Ann Arbor 240
Beijing 231
Cambridge 231
Chandler 229
San Jose 222
Seattle 203
The Dalles 195
Princeton 177
Wilmington 176
Nanjing 139
New York 137
Brescia 104
Dearborn 98
Lauterbourg 95
Helsinki 93
Dublin 92
Istanbul 85
Los Angeles 79
Des Moines 67
Ho Chi Minh City 65
Nanchang 54
Buffalo 51
Munich 51
São Paulo 48
Milan 40
Hanoi 39
Moscow 38
Hebei 37
Jiaxing 37
Shenyang 37
Basel 35
Council Bluffs 35
Dong Ket 34
Changsha 32
Dallas 32
Santa Clara 32
Tianjin 28
London 27
Shanghai 27
Jinan 26
Orem 26
San Francisco 26
Brussels 24
Chicago 24
Rio de Janeiro 24
San Donà Di Piave 24
San Diego 22
Abuja 20
Turku 20
Redondo Beach 19
Toronto 19
Jakarta 18
Brooklyn 17
Pune 16
Rome 16
Lancaster 15
Leawood 15
Montreal 15
Phoenix 15
Hangzhou 14
Hefei 14
Kunming 14
Frankfurt am Main 13
San Mateo 13
Atlanta 12
Boston 12
Brno 12
Guangzhou 12
Teramo 12
Zhengzhou 12
Boardman 11
Denver 11
Verona 11
Guayaquil 10
Lanzhou 10
Manchester 10
Mexico City 10
Ningbo 10
Tokyo 10
Brasília 9
Charlotte 9
Haiphong 9
Johannesburg 9
Norwalk 9
Taizhou 9
Vienna 9
Ardabil 8
Augusta 8
Baghdad 8
Belo Horizonte 8
Changchun 8
Chennai 8
Totale 8.142
Salva come PNG Salva come JPEG
Nome #
Ropinirole and Pramipexole Promote Structural Plasticity in Human iPSC-Derived Dopaminergic Neurons via BDNF and mTOR Signaling 323
Redistribution of DAT/α-synuclein complexes visualized by “in situ” proximity ligation assay in transgenic mice modelling early Parkinson’s disease 314
Pre-synaptic dopamine D(3) receptor mediates cocaine-induced structural plasticity in mesencephalic dopaminergic neurons via ERK and Akt pathways 271
Nicotine-induced structural plasticity in mesencephalic dopaminergic neurons is mediated by dopamine d3 receptors and akt-mtorc1 signaling 261
Ketamine enhances structural plasticity in human dopaminergic neurons: Possible relevance for treatment-resistant depression 221
Alpha-synuclein aggregation and cell death triggered by energy deprivation and dopamine overload are counteracted by D2/D3 receptor activation 192
Pluripotent Stem Cell Based Cultures to Study Key Aspects of Human Cerebral Cortex Development 180
Cloning of P2X5 and P2X6 receptors and the distribution and properties of an extended family of ATP-gated ion channels 178
Structural plasticity induced by ketamine in human dopaminergic neurons as mechanism relevant for Treatment-Resistant Depression 176
(2 R,6 R)-Hydroxynorketamine promotes dendrite outgrowth in human inducible pluripotent stem cell-derived neurons through AMPA receptor with timing and exposure compatible with ketamine infusion pharmacokinetics in humans 172
Derivation of midbrain dopaminergic neurons from human inducible pluripotent stem cells to model neurological disorders. 164
Structural plasticity in mesencephalic dopaminergic neurons produced by drugs of abuse: critical role of BDNF and dopamine 163
A human translational model based on neuroplasticity for pharmacological agents potentially effective in Treatment-Resistant Depression: Focus on dopaminergic system 163
The novel hybrid agonist HyNDA-1 targets the D3R-nAChR heteromeric complex in dopaminergic neurons 161
Ketamine increases the expression of GluR1 and GluR2 α-amino-3-hydroxy-5-methy-4-isoxazole propionate receptor subunits in human dopaminergic neurons differentiated from induced pluripotent stem cells 160
Ketamine enhances structural plasticity in mouse mesencephalic and human iPSC-derived dopaminergic neurons via AMPAR-driven BDNF and mTOR signaling 152
An antagonist-insensitive P2X receptor expressed in epithelia and brain 151
ATP mediated cytotoxicity in microglial cells. 149
Blockade of human P2X7 receptor function with a monoclonal antibody. 148
Distictive functions of a6b4 and other integrins in epithelial cells. 145
P2X1 receptor activation in HL60 cells. 144
Pharmacological targeting of dopamine D3 receptors: Possible clinical applications of selective drugs. 143
A direct interaction between dopamine D1 receptor and phosphatase Shp-2 triggers Erk activation in striatal neurons 141
Ketamine effects on mammalian target of rapamycin signaling in the mouse limbic system depend on functional dopamine D3 receptors 139
The NMDA/D1 receptor complex as a new target in drug development 137
Purinoceptors in the central nervous system 136
Dopamine D3 receptors are critically involved in the neurotrophic effects of cocaine and nicotine on the mouse mesencephalic dopaminergic neurons 133
Critical role of dopamine D3 receptor in structural plasticity generated by exposure to drugs of addiction in mesencephalic dopaminergic neurons 133
Genetic variation in CHRNA7 and CHRFAM7A is associated with nicotine dependence and response to varenicline treatment 130
Tissue distribution of the P2X7 receptor 129
The tyrosine phosphatase Shp-2 interacts with the dopamine D(1) receptor and triggers D(1) -mediated Erk signaling in striatal neurons. 129
Alpha-synuclein aggregation in dopaminergic cells is modulated by glucose metabolism 128
A new isoform of the laminin receptor α7β1 is developmentally regulated in skeletal muscle. 127
The neurobiology of dopamine receptors: evolution from the dual concept to heterodimer complexes 127
Immature neuronal phenotype derived from mouse skin precursor cells differentiated in vitro. 125
Dopamine D3 receptor-preferring agonists increase dendrite arborization of mesencephalic dopaminergic neurons via extracellular signal-regulated kinase phosphorylation. 125
In-vivo silencing of the tyrosine phosphatase Shp-2 ameliorates L-DOPA-induced dyskinesia in a rat model of Parkinson’s disease 125
Alphα6-containing nicotinic acetylcholine receptors mediate nicotine-induced structural plasticity in mouse and human iPSC-derived dopaminergic neurons 125
D3 receptor involvement in neurotrophic effects of amphetamine and cocaine on mesencephalic dopaminergic neurons 124
Attenuated acute effects of ketamine on mTOR pathway in the limbic system of dopamine D3 receptor knock-out mice 121
Dopamine D3 receptor and beta-2 containing nicotinic acetylcholine receptor are critical in mediating nicotine effects on dopaminergic neurons morphology 119
P2X receptors: an emerging channel family. 118
Differential onset of expression of alpha7 and beta1D integrins during mouse heart and skeletal muscle development. 117
CRISPR targeting of human induced pluripotent stem cells (HIPSCS) for lineage tracing of HIPSCS-derived neural stem cells during cortical development in vitro 117
Cell-type specific integrin variants with alternative α chain cytoplasmic domain 116
Neuroadaptation mechanisms to nicotine in mesencephalic dopaminergic neurons: role of dopamine D3 receptor and nicotinic acetylcholine receptors. 116
Morphogenetic changes produced by cocaine and nicotine in mesencephalic dopaminergic neurons: role of dopamine D3 receptor 115
Expansion of human midbrain floor plate progenitors from induced pluripotent stem cells increases dopaminergic neuron differentiation potential 115
Knock-down of the tyrosine phosphatase Shp-2 ameliorates L-DOPA-induced dyskinesia in a rat model of parkinson's disease. 114
Ketamine produces structural plasticity in dopaminergic neurons via co-activation of MEK-ERK and Akt-mTOR pathways: translation from mouse primary culture to human iPSC-derived neurons 114
Dopamine D1R activation triggers Erk1/2 activation in striatal neurons through the interaction with the protein tyrosine phosphatase Shp-2. 113
Dopamine-induced Erk activation in striatal neurons is mediated by a direct interaction between the D1 receptor and the tyrosine phosphatase Shp-2. 112
Neurotrophic effects of cocaine on mouse mesencephalic dopaminergic neurons are mediated by dopamine D3 receptors 112
Role of dopamine D1 receptor and phosphatase Shp-2 in L-DOPA-induced dyskinesia in a rat model of Parkinson's disease. 112
The Shp-2 tyrosine phosphatase interacts with the dopamine D1 receptor and triggers D1-mediated Erk signalling in striatal neurons. 110
Molecular mechanisms underlying dopamine D1R-dependent activation of striatal Erk1/2 in L-DOPA induced dyskinesia in a rat model of Parkinson’s disease. 110
Dopamine D1R activation modulates intracellular signalling and triggers Erk1/2 activation in striatal neurons through the interaction with the protein tyrosine phosphatase Shp-2. 109
Nicotine produces structural plasticity of mesencephalic dopaminergic neurons via activation of Akt-mTor pathway 109
Ketamine produces structural plasticity in dopaminergic neurons in vitro via co-activation of MEK-ERK and Akt-mTOR pathways: role of BDNF and dopamine D3 receptor 109
Dopamine agonists produce neurotrophic effects on mesencephalic dopaminergic neurons via dopamine D3 receptor activation 108
Spontaneous cell fusion in macrophage cultures expressing high levels of the P2Z/P2X7 receptor. 107
Selective dopaminergic alpha-synuclein pathological changes following glucose deprivation "in vitro": implications for Parkinson's disease 107
Ketamine produces structural plasticity of mouse mesencephalic dopaminergic neurons via activation of Akt-mTOR pathway: role of dopamine D3 receptor. 106
Glimpse into cell reprogramming: emerging role of progesterone receptor in priming potency of induced pluripotent stem cells (iPSCs). 105
Effetti neurotrofici dei farmaci agonisti preferenziali D3 sui neuroni mesencefalici: implicazioni terapeutiche per la malattia di Parkinson. 105
Nicotine enhances the neuroplasticity of dopamine neurons: role of dopamine D3 receptors and acetylcholine nicotinic receptors. 103
Oxide Nanowires for Neuron Adhesion and Growth 103
Negative Symptoms of Schizophrenia and Dopaminergic Transmission: Translational Models and Perspectives Opened by iPSC Techniques 102
Human iPS cell-derived dopaminergic neurons reveal role for D3 receptors and mTOR in induction of structural plasticity by antiparkinson DA agonists 101
Distinct alpha7A-beta1 and alpha7B-beta1 integrin expression patterns during mouse development: alpha7A is restricted to skeletal muscle but alpha7B is expressed in striated muscle, vasculature, and nervous system. 100
The integrin alpha6beta4 in epithelial and carcinoma cells 99
Testing drugs for structural plasticity in dopaminergic neurons: translation from mouse primary cell culture to human iPSC-derived neurons 99
Testing the effect of dopamine agonists and of drugs of addiction on structural plasticity of dopaminergic neurons: translation from mouse primary cell culture to human iPSC-derived neurons 97
Evidence for soluble Interleukin-2 receptor (IL-2) as immunosuppressive factor. 96
Glimpse into cell reprogramming: emerging role of progesterone receptor in priming potency of induced pluripotent stem cells (iPSCs) 94
Gradient of integrin α6A expession in the myocardium during early heart development. 91
Long-term expansion of dopaminergic progenitors from human induced pluripotent stem cells (iPSCs) and differentiation into dopaminergic neurons in vitro and in vivo 91
Dopamine D3 receptor ligands for drug addiction treatment: update on recent findings 91
Nicotine enhances structural plasticity in mesencephalic dopaminergic neurons: involvement of dopamine D3 receptors and nicotinic acetylcholine receptors. 90
Loss of Synaptic D1 Dopamine/N-Methyl-D-aspartate Glutamate Receptor Complexes in L-DOPA-Induced Dyskinesia in the Rat. 88
Involvement of nicotinic acetylcholine receptors and dopamine D3 receptors in structural plasticity of dopaminergic neurons 88
Myogenic conversion of NIH3T3 cells by exogenous MyoD family members: dissociation of terminal differentiation from myotube formation. 86
Endothelial cell integrin alpha5beta1 expression is modulated by cytokines and during migration in vitro. 85
Neuroprotective effects of D2/D3 agonists in an "in vitro" model of dopaminergic degeneration 85
Involvement of DA D3 Receptors in Structural Neuroplasticity of Selected Limbic Brain Circuits: Possible Role in Treatment-Resistant Depression 84
Mouse dendritic cells express the P2X7 purinergic receptor: characterization and possible participation in antigen presentation. 83
Dopamine D3 receptors mediate the neurotrophic effects of dopaminergic agonists on mesencephalic dopaminergic neurons. 83
Dopamine D3 receptors mediate the neurotrophic effects of dopaminergic agonists on mesencephalic dopaminergic neurons 82
Glimpse into cell reprogramming: emerging role of progesterone receptor in priming potency of induced pluripotent stem cells (iPSCs). 79
The permeabilizing ATP receptor, P2X7. Cloning and expression of a human cDNA. 78
Meccanismo molecolari e cellulari nel Morbo di Parkinson 78
Downregulation of dopamine D1/NMDA receptor complexes in the post synaptic densities of dyskinetic rats 75
Progesterone receptor is constitutively expressed in induced Pluripotent Stem Cells (iPSCs) 74
Progesterone receptor is constitutively expressed in induced Pluripotent Stem Cells (iPSCs) 74
Nicotine produces neurotrophic effects on mesencephalic dopaminergic neurons: role of dopamine D3 receptors and nicotinic acetylcholine receptors 70
Pharmacology profile of F17464, a dopamine D3 receptor preferential antagonist 70
Progesterone receptor is constitutively expressed in induced Pluripotent Stem Cells (iPSCs) 68
Cortisol-dependent impairment of dendrite plasticity in human dopaminergic neurons derived from hiPSCs is restored by ketamine: Relevance for major depressive disorders 68
Glimpse into cell reprogramming: emerging role of progesterone receptor in priming potency of induced pluripotent stem cells (iPSCs) 68
Progesterone receptor is constitutively expressed in induced Pluripotent Stem Cells (iPSCs) 64
Totale 12.247
Salva come PNG Salva come JPEG
Categoria #
all - tutte 55.097
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 55.097
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202157 0 0 0 0 0 0 0 0 0 0 0 57
2021/2022667 62 140 4 18 9 19 30 43 30 75 54 183
2022/2023627 93 3 10 54 57 187 4 64 106 0 15 34
2023/2024651 41 10 52 53 32 147 28 23 131 17 14 103
2024/20251.762 2 40 24 253 157 118 135 35 240 165 367 226
2025/20263.337 320 433 214 411 307 186 588 159 189 290 147 93
Totale 12.511